SEC Tracker
Get the app

Possible new ERNA shares

ERNADilution

Known so far: no new shares from the prospectus covers read · shelf room about $5.8M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $5.8M
  • One third of float $5.8M ($17.5M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $5.8M on the S-3 of Mar 24, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $17.5M public float stated as of Jun 30, 2025, $5.8M, nothing sold off it in the last 12 months. Sources: S-3/A Mar 24, 2026, effective Mar 30, 2026 · public float, as of Jun 30, 2025.

What could become new Ernexa Therapeutics (ERNA) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (1.6M shares, +432% from 307K on Aug 12, 2025, adjusted for the 1-for-25 reverse split by May 8, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

1.6M

Nov 2024 to Aug 2026: from 137K to 1.6M. Adjusted for two reverse splits, 1-for-15 by Aug 12, 2025 and 1-for-25 by May 8, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.